Shares of Zydus Lifesciences jumped more than 7% on Wednesday to hit a fresh 52-week high of Rs 1,091 apiece on the NSE after the pharma company reported a 9% year-on-year (YoY) increase in consolidated net profit to Rs 1,272.5 crore for the January-March quarter of FY26, up from Rs 1,171 crore in the corresponding period last year.
While the bottom line grew 9%, the company’s revenue from operations rose more than 16% YoY to Rs 7,587 crore during the quarter under review, compared with Rs 6,528 crore in the year-ago period. Its EBITDA, meanwhile, grew over 20% YoY to Rs 2,554 crore in the fourth quarter of the financial year ended March 31, 2026, while the EBITDA margin improved to 33.7%.
